Osteopontin is required for vascular endothelial growth factor receptor-1-mediated vascular inflammation in vascular adventitia

xiaodong li,jing chen,dingliang zhu,pingjin gao
DOI: https://doi.org/10.1016/j.ijcard.2011.08.742
IF: 4.039
2011-01-01
International Journal of Cardiology
Abstract:Objectives: Our previous study found that increased expression of vascular endothelial growth factor receptor-1 (Flt-1) and osteopontin (OPN) is associated with arterial injury in adventitia. This study tested the hypothesis that ligand activation of Flt-1 stimulates OPN expression by exerting a chemotactic effect on adventitial fibroblasts (AFs) and macrophage mediating vascular inflammation. Methods and results: In primary cultured aortic AFs, vascular endothelial growth factor (VEGF) enhanced the expression of OPN in a time- and dose-dependent manner via activation of Protein kinase B (AKT) and extracellular signal-regulated kinase (ERK) signaling pathway. VEGF induced expression and migration of OPN was effectively inhibited by anti-Flt-1 peptide, a Flt-1-specific hexapeptide. We also demonstrated that AFs migration induced by VEGF in a concentration-dependent was inhibited by anti-Flt-1 peptide or OPN neutralizing antibody respectively. Interestingly, VEGF treatment enhanced AF-conditioned medium-stimulated macrophage migration, and this effect was inhibited by pretreatment of AF-conditioned medium with OPN neutralizing antibody. Furthermore, after balloon injury of rat carotid artery, VEGF and OPN expression was significantly increased especially in the adventitia. Administered anti-Flt-1 peptide localized preferentially to the adventitia in the injured carotid artery, causing a reduction in developing neointima formation and an increase in lumen area. Perivascular delivery of anti-Flt-1 peptide also inhibited increased expression of OPN which was coincided with reduced macrophage infiltration in adventitia. Conclusions: These results demonstrate that the expression of OPN plays a major role in Flt-1-mediated vascular inflammation in vascular adventitia and provide insight into anti-Flt-1 as a potential therapeutic target for vascular diseases.
What problem does this paper attempt to address?